| abstract |
Disclosed is an implantable medical device comprising high density lipoprotein (HDL), recombinant HDL, high density lipoprotein mimic (HDLm), or a combination thereof. Also disclosed are local and systemic administration methods of HDL, recombinant HDL, or HDLm for the prevention, treatment, or amelioration of vascular disorders such as restenosis or vulnerable plaque, vascular disease, or vascular occlusion. |